Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Discovery Grants Program - Individual

University of Saskatchewan

$37,000.00

Infection phenotypes of CpG-recoded RNA viruses in animal models with immature immunity

FY 2020-21

Summary
The long-term goal of the proposed research program is to understand better how increasing the number of CpG (cytosine-phosphate-guanine) dinucleotides in viral genomes affects infection and host immune responses and harness this knowledge to improve vaccination in the veterinary field. We are particularly interested in vaccine technology that will be safe to apply during pregnancy and in newborn and young animals with immature immunity. Increasing CpG dinucleotide numbers in RNA viral genomes, while preserving natural amino acid composition of proteins and antigenic profile, attenuates infection. Attenuated infection, however, leads to robust immune responses. It has been demonstrated that host immunity more efficiently targets CpG-recoded mutants than wild-type viruses. Despite significant progress, there is no full understanding of the mechanism(s) through which CpG composition influences virulence. In addition to exciting fundamental questions of virus-host interactions, CpG recoding potentially provides a cutting-edge technology for safer live vaccines, which will cause attenuated infection, no pathology, but robust immune responses. So far, one CpG vaccine candidate has been characterized in adult mice, showing promising results. However, safety margins of the CpG recoding technology in general, and particularly in animals with an immature immune system, are not defined. We chose to work with Zika virus (ZIKV) as a model because it affects fetuses and neonates. Our research applies a novel reverse genetics system to manipulate CpG frequencies in viral RNA genomes, a neonatal mouse model, and the first fetal pig model for ZIKV infection in the world. To better understand how increasing of CpG dinucleotides in an RNA viral genome affects infection and to determine if increasing of CpG dinucleotides leads to attenuated infection phenotypes in neonates and fetuses, we will address four objectives: First, we will evaluate a mechanistic relationship between the number of CpG dinucleotides in an RNA viral genome and infection phenotypes in different cell lines. Second, we will compare infection outcomes (clinical signs/mortality) and immune responses in newborn animals infected with wild and CpG-recoded ZIKV. Finally, we will address in utero infection kinetics, pathology, and immune responses to wild and CpG-recoded viruses in fetuses at the early stage and mid-stage of development. These experiments will improve our understanding of how CpG recoding in viral genomes affects infection and host immunity, and safety margins of the CpG-recoded viruses in animals with immature immunity. This basic knowledge will influence theories and application of the CpG vaccine technology particularly in the veterinary field benefiting Canadians and global community. Significantly, the program will also provide outstanding multidisciplinary training for young researchers.
Program
Discovery Grants Program - Individual
Location
Saskatchewan, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data

As published

Application id
RGPIN-2018-04904
Name nom
Karniychuk, Uladzimir
Department département
VIDO-InterVac
Organization id
16
Institution établissement
University of Saskatchewan
Province en
Saskatchewan
Province fr
Saskatchewan
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2020
Competition year année de concours
2018
Award amount
37000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
5202
Research subject group en
Microbiology
Research subject group fr
Microbiologie
Research subject en
Virology
Research subject fr
Virologie
Installment
inst:3-5
Partie
3
Nb partie
5
Application title
Infection phenotypes of CpG-recoded RNA viruses in animal models with immature immunity
Keyword
NSERC
Application summary
The long-term goal of the proposed research program is to understand better how increasing the number of CpG (cytosine-phosphate-guanine) dinucleotides in viral genomes affects infection and host immune responses and harness this knowledge to improve vaccination in the veterinary field. We are particularly interested in vaccine technology that will be safe to apply during pregnancy and in newborn and young animals with immature immunity. Increasing CpG dinucleotide numbers in RNA viral genomes, while preserving natural amino acid composition of proteins and antigenic profile, attenuates infection. Attenuated infection, however, leads to robust immune responses. It has been demonstrated that host immunity more efficiently targets CpG-recoded mutants than wild-type viruses. Despite significant progress, there is no full understanding of the mechanism(s) through which CpG composition influences virulence. In addition to exciting fundamental questions of virus-host interactions, CpG recoding potentially provides a cutting-edge technology for safer live vaccines, which will cause attenuated infection, no pathology, but robust immune responses. So far, one CpG vaccine candidate has been characterized in adult mice, showing promising results. However, safety margins of the CpG recoding technology in general, and particularly in animals with an immature immune system, are not defined. We chose to work with Zika virus (ZIKV) as a model because it affects fetuses and neonates. Our research applies a novel reverse genetics system to manipulate CpG frequencies in viral RNA genomes, a neonatal mouse model, and the first fetal pig model for ZIKV infection in the world. To better understand how increasing of CpG dinucleotides in an RNA viral genome affects infection and to determine if increasing of CpG dinucleotides leads to attenuated infection phenotypes in neonates and fetuses, we will address four objectives: First, we will evaluate a mechanistic relationship between the number of CpG dinucleotides in an RNA viral genome and infection phenotypes in different cell lines. Second, we will compare infection outcomes (clinical signs/mortality) and immune responses in newborn animals infected with wild and CpG-recoded ZIKV. Finally, we will address in utero infection kinetics, pathology, and immune responses to wild and CpG-recoded viruses in fetuses at the early stage and mid-stage of development. These experiments will improve our understanding of how CpG recoding in viral genomes affects infection and host immunity, and safety margins of the CpG-recoded viruses in animals with immature immunity. This basic knowledge will influence theories and application of the CpG vaccine technology particularly in the veterinary field benefiting Canadians and global community. Significantly, the program will also provide outstanding multidisciplinary training for young researchers.
University of Saskatchewan - $37,000 Grant (2020-21) | Canada Spends